PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Oculis Reports Results of OCS-01 in P-II (DX-211) Study for the Treatment of Diabetic Macular Edema

Oculis Reports Results of OCS-01 in P-II (DX-211) Study for the Treatment of Diabetic Macular Edema

September 6, 2022

John Strickler, Associate Professor of Medicine, Duke University School of Medicine, Shares Insights from the P-II Study at the 2022 ESMO World Congress on Gastrointestinal Cancer

John Strickler, Associate Professor of Medicine, Duke University School of Medicine, Shares Insights from the P-II Study at the 20...

September 6, 2022

Abivax Publishes Results of Obefazimod (ABX464) in P-IIb Trial for the Treatment of Ulcerative Colitis in the Lancet Gastroenterology & Hepatology

Abivax Publishes Results of Obefazimod (ABX464) in P-IIb Trial for the Treatment of Ulcerative Colitis in the Lancet Gastroenterol...

September 6, 2022

Bertis Publishes Result on Proteomic Based Research of New Biomarker for the Diagnosis of Ovarian Cancer

Bertis Publishes Result on Proteomic Based Research of New Biomarker for the Diagnosis of Ovarian Cancer

September 6, 2022

Rhythm’s Imcivree (setmelanotide) Receives EC’s Approval for the Treatment of Bardet-Biedl Syndrome

Rhythm’s Imcivree (setmelanotide) Receives EC’s Approval for the Treatment of Bardet-Biedl Syndrome

September 6, 2022

CVS Health to Acquire Signify Health for ~$8B

CVS Health to Acquire Signify Health for ~$8B

September 6, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us